πŸ‡ΊπŸ‡Έ FDA
Patent

US 9434703

Viloxazine compositions

granted A61PA61P13/00A61P25/00

Quick answer

US patent 9434703 (Viloxazine compositions) held by Supernus Pharmaceuticals, Inc. expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P13/00, A61P25/00, A61P25/20, A61P25/24